Target intelligence / Profile preview

Hemozoin (beta-hematin) (Hz)

Target
Hz
Molecular classification
Biocrystal, Metabolic byproduct, Porphyrin derivative
01

Overview

Hemozoin, commonly referred to as malaria pigment, is a dark-brown biocrystal synthesized by Plasmodium parasites during their intraerythrocytic stage. As the parasite digests host hemoglobin to obtain essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic to the parasite due to its ability to generate reactive oxygen species and destabilize lipid membranes (Sullivan, 2002, International Journal for Parasitology). To survive, the parasite detoxifies this heme by sequestering it into chemically inert, insoluble hemozoin crystals within its acidic digestive vacuole (Coronado et al., 2014, Toxins). This crystallization process is a vital metabolic pathway and serves as the primary therapeutic target for the quinoline class of antimalarial drugs. Drugs such as chloroquine and quinine accumulate in the digestive vacuole and bind to the growing faces of the hemozoin crystal or to free heme itself, preventing further crystallization (Egan, 2008, Journal of Inorganic Biochemistry). This interference results in a lethal buildup of toxic free heme, which ultimately destroys the parasite's internal membranes and leads to cell death (Weissbuch & Leiserowitz, 2008, Chemical Reviews).

Other names
Malaria pigmentBeta-hematinFerriprotoporphyrin IXHeme crystalFP-IX
02

Mechanism of action

Inhibition of heme biocrystallization (the conversion of toxic free heme into inert hemozoin), leading to the accumulation of toxic ferriprotoporphyrin IX which causes oxidative stress and membrane lysis within the parasite.

03

Biological functions

Heme detoxificationHemoglobin catabolismIron sequestration
04

Disease associations

MalariaInfection
05

Safety considerations

Drug resistance mediated by mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT)Retinopathy (associated with long-term quinoline use)Cardiotoxicity (QT interval prolongation)Neurotoxicity (associated with specific quinolines like mefloquine)
06

Interacting drugs

Chloroquine

8 more in the full profile.

07

Biomarkers

Hemozoin levels (detected via polarized light microscopy or magneto-optical methods)Plasmodium falciparum histidine-rich protein 2 (HRP2)Intraerythrocytic parasite density

Beyond the preview

Go deeper on Hemozoin (beta-hematin) (Hz).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin (beta-hematin) (Hz).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call